Try our Advanced Search for more refined results

Molecular Insight Hits USPTO Over Patent Terms

By Melissa Lipman (December 3, 2008, 12:00 AM EST) -- Molecular Insight Pharmaceuticals Inc. has filed two suits against the U.S. Patent and Trademark Office over its refusal to extend the term patents owned or licensed by the drug company in the latest of a string of patent term adjustment actions following a recent district court decision against the agency....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!